UnknownNCT01154907
Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oslo University Hospital
- Principal Investigator
- Eyrun F Kjetland, MD, PhDOslo University Hospital, University of KwaZulu-Natal (UKZN)
- Intervention
- Praziquantel(drug)
- Enrollment
- 6500 enrolled
- Eligibility
- 10-23 years · FEMALE
- Timeline
- 2010 – 2021
Study locations (1)
- University of KwaZulu Natal, Durban, KwaZulu-Natal, South Africa
Collaborators
University of KwaZulu · University of Agder · Sorlandet Hospital HF · University of Copenhagen · Leiden University Medical Center · Universiteit Antwerpen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01154907 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06698510Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyPeter Steinmann
- RECRUITINGNANCT06873308Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic SchistosomiasisIRCCS Sacro Cuore Don Calabria di Negrar